Recorded Webinar
An introduction to Particle Works, its technology and product roadmap

Thank you for your interest in our webinar. In this session we talked about how automated microfluidics have significant potential for removing the common roadblocks to progress in nanoparticle-based therapies, such as time delays and financial limitations, contributing to advances in the clinical development of nanomedicines.

The webinar was hosted by Lee Jeffries, Managing Director of Particle Works; Gareth Bolitho, Commercial Manager; and Ben Knappett, Head of Science and Applications.

Recently spun out of Dolomite Microfluidics, Particle Works designs and manufactures state-of-the-art automated nanoparticle synthesis platforms for drug delivery solutions. Our technology is used in a wide range of applications, including the production of nanoparticle-based vaccines, medicines, and therapeutics. We have been at the forefront of this rapidly changing science, listening and adapting as our customers’ needs have evolved. Our platforms enable scientists to formulate particles faster, ensuring they are ready for their next breakthrough and the scale up of discoveries.

Get in touch
Got questions after viewing the webinar? Drop us a message to speak with one of our particle experts. We'd love to share more about our technology, and demonstrate how we can help you unlock the true power of particles.
Further reading